about
Possible pathogenetic role of activated platelets in the primary antiphospholipid syndrome involving the central nervous system.Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's diseaseHuman striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation.Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease.Brain metabolic differences between sporadic and familial Alzheimer's disease.Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson's disease patients.MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.Development of human striatal anlagen after transplantation in a patient with Huntington's disease.Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: measurement of arterial input and brain retention.Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study.Parkinsonism and Anderson Fabry's disease: a case report.A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements.Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's diseaseUse of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet's diseaseEvaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET
P50
Q33500271-6E0FFBC2-86B6-45AB-ACE5-926261FD73F1Q35480015-E99A9E3E-C1E2-418D-AB63-F3C12776A09AQ43212739-21F7692E-1386-4183-990B-62B8B8B55B8CQ43281611-C5E5D341-03CC-48EB-9645-1ADF4163EBA4Q44634161-7A09EF77-B608-4089-BCEA-76AC9AD090DCQ44806650-B2573268-C214-4B47-97E0-4EF54B632B88Q45185675-C4B7FE0A-AAB4-4B99-9EB7-28AAD8FA1A21Q45205183-D7F89950-C177-4A12-BA2E-34884F79F263Q45289953-DE5DBCBF-85DA-4736-91F6-0F4E47C947B1Q48181640-F8334F31-F08D-46C5-920E-58DC2D0AC209Q48306173-735031B8-9B23-4860-A4D7-F8AD50F440D3Q48783024-9F18C8D2-FE5B-447B-B1BE-C7D7F0C8F376Q51037078-8CAA4D28-B285-4F27-AD48-6A97FE59FFF7Q57988220-2D911463-48AE-40A3-A041-E2A63B84FCDDQ57988318-00C98F9D-213D-4CF3-BC5B-6D269493554CQ57988338-EF1BBC50-D7E4-48DC-AC0C-D4A535403448
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1702-0684
@en
name
Maria Teresa De Cristofaro
@ast
Maria Teresa De Cristofaro
@en
Maria Teresa De Cristofaro
@es
Maria Teresa De Cristofaro
@nl
type
label
Maria Teresa De Cristofaro
@ast
Maria Teresa De Cristofaro
@en
Maria Teresa De Cristofaro
@es
Maria Teresa De Cristofaro
@nl
altLabel
Maria Teresa Rosaria De Cristofaro
@en
prefLabel
Maria Teresa De Cristofaro
@ast
Maria Teresa De Cristofaro
@en
Maria Teresa De Cristofaro
@es
Maria Teresa De Cristofaro
@nl
P106
P1153
8330792300
P21
P31
P496
0000-0003-1702-0684